Clinical trial

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given…

NCT00174811 · Sanofi, Industry · Terminated

Key facts

NCT number NCT00174811
Title Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections
Official title Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of Telithromycin 25 mg/kg Given Once Daily for 5 or 10 Days Depending on Age and Previous Treatment History Versus Cefuroxime Axetil 15 mg/kg, Given Twice Daily for 10 Days, in Children With…
Lead sponsor Sanofi, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Otitis Media
Intervention type Drug
Interventions telithromycin (HMR3647)
Enrollment 639
Start date Jun 1, 2005
Primary completion Jun 1, 2006
Completion Jun 1, 2006
First posted Sep 15, 2005
Last update posted Apr 3, 2009
Countries France, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies